Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Long-Acting Injectable Clozapine Not Available in the United States.

Subjects: Clozapine* ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use; Humans

  • Source: American family physician [Am Fam Physician] 2023 Jun; Vol. 107 (6), pp. 568.Publisher: American Academy of General Practice Country of Publication: United States NLM ID: 1272646 Publication Model: Print

Record details

×
Academic Journal

Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.

  • Authors : Kane JM; The Zucker Hillside Hospital, Northwell Health, Department of Psychiatry, Glen Oaks, New York.; Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/diagnosis ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Apr 19; Vol. 84 (3). Date of Electronic Publication: 2023 Apr 19.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Electronic

Record details

×
Academic Journal

Association of T-wave abnormalities with major cardiovascular events in diabetes: the ACCORD trial.

  • Authors : Mould SJ; Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Soliman EZ

Subjects: Action Potentials* ; Electrocardiography* ; Heart Rate*

  • Source: Diabetologia [Diabetologia] 2021 Mar; Vol. 64 (3), pp. 504-511. Date of Electronic Publication: 2021 Jan 08.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Environmental Decision-Making in Times of Polarization.

Subjects: Decision making; Polarization (Social sciences); Collective actionUnited States

  • Source: Annual Review of Environment & Resources. Nov2023, Vol. 48, p477-503. 27p.

Record details

×
Academic Journal

How Hazardous Is Your State to Your Health?

Subjects: Public Health; Death; Mortality RateUnited States

  • Source: American Journal of Health Education. 2024 55(1):1-13.13

Record details

×
Academic Journal

Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia.

  • Authors : Rubio JM; The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy; Aged

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2023 Feb 13; Vol. 84 (2). Date of Electronic Publication: 2023 Feb 13.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Electronic

Record details

×
Academic Journal

Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?

  • Authors : Roe M; Mountain Area Health Education Center (MAHEC), Asheville, NC, USA.; Wilson CG

Subjects: Administration, Sublingual* ; Injections, Intramuscular*; Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/Buprenorphine, Naloxone Drug Combination/*administration & dosage

  • Source: The Journal of family practice [J Fam Pract] 2020 Dec; Vol. 69 (10), pp. E14-E15.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print

Record details

×
Academic Journal

Application of Clinical Pharmacology Principles in Drug Development of Modified-Release Products: Leveraging Exposure-Response Information to Support Approval.

  • Authors : AbuAsal BS; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.; Hamed SS

Subjects: Drug Development*; Delayed-Action Preparations/Delayed-Action Preparations/Delayed-Action Preparations/*pharmacokinetics ; Drug Approval/Drug Approval/Drug Approval/*methods

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Nov; Vol. 60 (11), pp. 1441-1452. Date of Electronic Publication: 2020 May 26.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

×